Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,176 | $33,232 | $32,407 | $32,427 |
| - Cash | $18,273 | $21,309 | $22,500 | $22,377 |
| + Debt | $12,374 | $11,701 | $11,430 | $9,924 |
| Enterprise Value | $28,278 | $23,624 | $21,337 | $19,975 |
| Revenue | $74,993 | $75,515 | $70,788 | $69,014 |
| % Growth | -0.7% | 6.7% | 2.6% | – |
| Gross Profit | $12,520 | $14,187 | $13,277 | $13,233 |
| % Margin | 16.7% | 18.8% | 18.8% | 19.2% |
| EBITDA | $4,901 | $6,458 | $6,271 | $5,760 |
| % Margin | 6.5% | 8.6% | 8.9% | 8.3% |
| Net Income | $2,835 | $4,056 | $3,967 | $3,720 |
| % Margin | 3.8% | 5.4% | 5.6% | 5.4% |
| EPS Diluted | 1.74 | 2.49 | 2.44 | 2.29 |
| % Growth | -30.1% | 2% | 6.6% | – |
| Operating Cash Flow | $3,442 | $4,104 | $6,999 | $5,673 |
| Capital Expenditures | -$1,128 | -$1,628 | -$1,384 | -$1,255 |
| Free Cash Flow | $2,314 | $2,475 | $5,615 | $4,419 |